Senior insider sale
CEO & President at DYNE THERAPEUTICS, INC. — senior position signals high conviction
$110.0K
5.99K shares
What this filing means
COX JOHN plans to sell 5.99K shares of DYNE THERAPEUTICS, INC. valued at approximately $110.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/16/2026ACC: 0001972481-26-000203
DirectorOfficer· CEO & President
Since Mar 2026
5.99K
Shares to sell
$110.0K
Approx. market value
9.08K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Units
Equity Compensation
6/4/2026
9.08KTotal acquired9.08K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/4/2026 | Restricted Stock Units Equity Compensation | 9.08K | — |
| Total | 9.08K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
3.31K
Market value
$60.8K
5/13/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
2.68K
Market value
$49.2K
6/16/2026
Total
Units
5.99K
Value
$110.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/13/2026 | 3.31K | $60.8K | — | Completed |
| Planned — Approximate Date | ||||
6/16/2026 | 2.68K | $49.2K | Nasdaq | Planned |
| Total | 5.99K | $110.0K | ||